कोशिश गोल्ड - मुक्त

Study-Abroad Startups Face Testing Times

Mint Hyderabad

|

June 16, 2025

With popular foreign-study destinations tightening visa rules for students, the industry has been hit hard

- Samiksha Goel

Bengaluru: Amarth G.S., 25, hasn't been to his hometown in Karnataka in nearly two years. But not for the usual reasons. Last year, he stayed back in the US to look for an internship. This year, even though he has one, he's hesitating because of tightening visa regulations.

"The situation is dicey here," said Amarth, who is studying for a master's degree. With only a brief window between the end of his internship and the start of the next academic term, he's worried that even a slight delay in returning could put his visa at risk. "Even if I come back a day late, they might use it as an excuse to cancel my visa," he said, referring to US President Donald Trump's regime.

Even when they are traveling within the US, universities are advising international students to carry their passports at all times.

Since Trump returned to power, the US's immigration policies have become draconian. On 27 May, the administration ordered US embassies around the world to stop scheduling appointments for student visas. It even halted Harvard University's ability to enroll foreign students. Amid all this, several international students have faced deportation for minor infractions.

While much of the attention around US visa restrictions has focused on students, the Big Brother approach in the US has made another group, India's study-abroad startups, anxious. Companies such as Leap Scholar, Leverage Edu, AdmitKard, and upGrad, which promise smooth overseas admissions and counseling services, are now facing business uncertainty.

Because it is not just the US, but key markets such as Canada, the UK, and Australia as well that have tightened rules for international student admissions, according to industry insiders.

After the crash of mainstream edtech in India, the study-abroad industry had emerged as a bright spot. But populist politics across the globe threaten to shake the foundations of the business model. Can these startups weather the storm?

Mint Hyderabad से और कहानियाँ

Mint Hyderabad

Mint Hyderabad

Nvidia, Eli Lilly to invest $1 bn in AI lab

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.

time to read

1 min

January 13, 2026

Mint Hyderabad

Shadowfax IPO to open next week

Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.

time to read

1 min

January 13, 2026

Mint Hyderabad

The US climate cop-out should galvanize others

America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US

time to read

2 mins

January 13, 2026

Mint Hyderabad

Toyota pushes for fuel norm clarity

The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.

time to read

1 min

January 13, 2026

Mint Hyderabad

Food effect lifts Dec CPI inflation

India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.

time to read

1 min

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Commissions trump advice in wealth management biz

surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.

time to read

2 mins

January 13, 2026

Mint Hyderabad

The Chinese company taking on the world's memory-chip giants

As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders

time to read

4 mins

January 13, 2026

Mint Hyderabad

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Hyderabad

Fix GST on capital goods to revive private investment

India faces a paradox today.

time to read

3 mins

January 13, 2026

Mint Hyderabad

Mint Hyderabad

Feeling tired? It could be too many messages

The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes

time to read

4 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size